Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics
J. Clin. Invest. Patrick Flood-Page, et al. 112:1029 doi:10.1172/JCI17974 [Go to this article.]

Figure 1
(a) A comparison of tenascin, lumican, and procollagen III expression in the reticular basement membrane between normal controls (n = 10) and asthmatic individuals (n = 11) before and after anti–IL-5. N denotes normal subjects. The crossbars represent the median values. (b) A comparison of the number of MBP⁺ eosinophils in the bronchial mucosa of normal controls and asthmatic subjects at baseline. (c) The correlation between eosinophil numbers and thickness of tenascin in the reticular basement membrane at baseline.